| scholarly article | Q13442814 |
| P2093 | author name string | Yi Li | |
| Feng Gao | |||
| Ruth Moysey | |||
| Tara Mahon | |||
| Brian Cameron | |||
| Bent K Jakobsen | |||
| Pierre J Rizkallah | |||
| Steven M Dunn | |||
| Emma Baston | |||
| Malkit Sami | |||
| Jonathan Boulter | |||
| P2860 | cites work | Selecting and maintaining a diverse T-cell repertoire | Q33783983 |
| A direct estimate of the human alphabeta T cell receptor diversity | Q33878476 | ||
| T cell receptor-MHC interactions up close | Q34132920 | ||
| Positive and negative selection of T cells | Q34157557 | ||
| The specificity of TCR/pMHC interaction | Q34493013 | ||
| Presentation of a self-peptide in two distinct conformations by a disease-associated HLA-B27 subtype | Q35634203 | ||
| T cell receptors: affinities, cross-reactivities, and a conformer model | Q35704672 | ||
| Negative selection imparts peptide specificity to the mature T cell repertoire | Q36161289 | ||
| High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease | Q36361794 | ||
| Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues | Q36366710 | ||
| Alteration at a single amino acid residue in the T cell receptor alpha chain complementarity determining region 2 changes the differentiation of naive CD4 T cells in response to antigen from T helper cell type 1 (Th1) to Th2. | Q36368633 | ||
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines | Q36403443 | ||
| HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides | Q36954248 | ||
| Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation | Q40785567 | ||
| Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. | Q40870242 | ||
| Biophysical studies of T-cell receptors and their ligands | Q41053752 | ||
| Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells | Q41198807 | ||
| Two-step binding mechanism for T-cell receptor recognition of peptide MHC. | Q42050788 | ||
| Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding | Q42153770 | ||
| The architecture of metal coordination groups in proteins | Q44855091 | ||
| Ligand recognition by alpha beta T cell receptors | Q46222293 | ||
| The T cell repertoire may be biased in favor of MHC recognition. | Q48356651 | ||
| Directed evolution of human T-cell receptors with picomolar affinities by phage display. | Q51538190 | ||
| Stable, soluble T-cell receptor molecules for crystallization and therapeutics | Q51812335 | ||
| How the T Cell Repertoire Becomes Peptide and MHC Specific | Q56922033 | ||
| Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition | Q74545050 | ||
| A very high level of crossreactivity is an essential feature of the T-cell receptor | Q77324273 | ||
| TCR binding to peptide-MHC stabilizes a flexible recognition interface | Q77328526 | ||
| A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening | Q24564781 | ||
| Improved methods for building protein models in electron density maps and the location of errors in these models | Q26776980 | ||
| Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor | Q27618536 | ||
| CDR3 loop flexibility contributes to the degeneracy of TCR recognition | Q27640417 | ||
| Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 | Q27733853 | ||
| Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids | Q27757472 | ||
| Shape complementarity at protein/protein interfaces | Q27860963 | ||
| Implementation of molecular replacement in AMoRe | Q27861032 | ||
| The CCP4 suite: programs for protein crystallography | Q27861090 | ||
| The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes | Q28139460 | ||
| T-cell antigen receptor genes and T-cell recognition | Q29619721 | ||
| In vitro evolution of a T cell receptor with high affinity for peptide/MHC. | Q30861962 | ||
| Specificity and degeneracy of T cells | Q33199993 | ||
| High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. | Q33211089 | ||
| Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization | Q33731073 | ||
| P433 | issue | 4 | |
| P921 | main subject | directed evolution | Q440681 |
| phage display | Q896217 | ||
| P304 | page(s) | 710-721 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Protein Science | Q7251445 |
| P1476 | title | Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity | |
| P478 | volume | 15 |
| Q39930758 | Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells? |
| Q38011650 | Challenges in T cell receptor gene therapy. |
| Q42006437 | Changing the peptide specificity of a human T-cell receptor by directed evolution. |
| Q27681832 | Computational Design of the Affinity and Specificity of a Therapeutic T Cell Receptor |
| Q94562689 | Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics |
| Q40151758 | Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells |
| Q42636244 | Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen |
| Q34186932 | Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire |
| Q27652700 | Different Thermodynamic Binding Mechanisms and Peptide Fine Specificities Associated with a Panel of Structurally Similar High-Affinity T Cell Receptors † ‡ |
| Q36497792 | Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy. |
| Q34513726 | Directed evolution of a fluorogen-activating single chain antibody for function and enhanced brightness in the cytoplasm |
| Q34436547 | Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function |
| Q30837264 | DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles |
| Q34624124 | Engineering improved T cell receptors using an alanine-scan guided T cell display selection system |
| Q37702226 | Enhanced T cell receptor gene therapy for cancer |
| Q47113506 | Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms. |
| Q90425510 | Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function |
| Q24642718 | Genetic engineering of T cells for adoptive immunotherapy |
| Q24324563 | High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation |
| Q92665367 | Human T-cell receptor V gene segment of alpha and beta families: A revised primer design strategy |
| Q34626991 | Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors. |
| Q26774669 | Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens |
| Q42129294 | Immune parameters to consider when choosing T-cell receptors for therapy |
| Q27678823 | Increased peptide contacts govern high affinity binding of a modified TCR whilst maintaining a native pMHC docking mode |
| Q60305288 | Integrating Experiment and Theory to Understand TCR-pMHC Dynamics |
| Q36080586 | Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness |
| Q38117139 | Molecular insights for optimizing T cell receptor specificity against cancer |
| Q34273053 | Monoclonal TCR-redirected tumor cell killing. |
| Q38335303 | Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions |
| Q34953926 | Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes |
| Q34037944 | Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function |
| Q35694340 | Quantitative Analysis of the Association Angle between T-cell Receptor Vα/Vβ Domains Reveals Important Features for Epitope Recognition |
| Q37107843 | Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies |
| Q36638160 | SHP-1 phosphatase activity counteracts increased T cell receptor affinity |
| Q36713758 | Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions |
| Q35602230 | Soluble T-cell receptors produced in human cells for targeted delivery. |
| Q34383054 | Specific increase in potency via structure-based design of a TCR. |
| Q35205495 | Specific roles of each TCR hemichain in generating functional chain-centric TCR. |
| Q90270564 | Stabilization of soluble high-affinity T-cell receptor with de novo disulfide bonds |
| Q41762286 | Structural features of T cell receptor variable regions that enhance domain stability and enable expression as single-chain ValphaVbeta fragments |
| Q37165240 | Structure-Based, Rational Design of T Cell Receptors |
| Q33366003 | Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. |
| Q35659205 | T Cell Receptor Engineering and Analysis Using the Yeast Display Platform |
| Q92245345 | T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance |
| Q27680546 | T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions |
| Q27678265 | T-cell Receptor Specificity Maintained by Altered Thermodynamics |
| Q36449599 | T-cell receptor gene therapy of established tumors in a murine melanoma model |
| Q92127499 | Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma |
| Q41816098 | The complex and specific pMHC interactions with diverse HIV-1 TCR clonotypes reveal a structural basis for alterations in CTL function |
| Q33833957 | Understanding TR binding to pMHC complexes: how does a TR scan many pMHC complexes yet preferentially bind to one. |
Search more.